Pourya Naderi Yeganeh

Pourya Naderi Yeganeh

Auto-generated profile, based on publicly available information

Pourya Naderi Yeganeh

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YZYing Zhang
Ying Zhang
XXXuemei Xie
Xuemei Xie
PYPourya Naderi Yeganeh
Pourya Naderi Yeganeh
DLDian-Jang Lee
Dian-Jang Lee
David Valle-GarciaDavid Valle-Garcia
David Valle-Garcia
JLJudy Lieberman
Judy Lieberman
Significance: Immunotherapy benefits some aggressive breast cancers, but many breast tumors do not respond to checkpoint blockade. Novel strategies to increase breast cancer immunogenicity are needed to improve immunotherapy. Here, we used epithelial cell adhesion molecule (EpCAM) aptamer-linked small-interfering RNA chimeras (AsiC) to selectively knock down genes in mouse breast cancers to induce tumor neoantigens or overcome immune evasion. Individual gene knockdown markedly delayed tumor growth and enhanced antitumor immunity. Cd47 and Parp1 AsiCs outperformed anti-CD47 antibody and the PARP1 inhibitor Olaparib, respectively. Combining EpCAM-AsiCs targeting multiple pathways worked better than single agents and enhanced tumor inhibition by a checkpoint inhibitor. EpCAM-AsiCs have the potential to boost immunity to tumors that are poorly responsive to checkpoint blockade.

1 October 2025 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
ICIsabel Castanho
Isabel Castanho
PYPourya Naderi Yeganeh
Pourya Naderi Yeganeh
CBCarles A. Boix
Carles A. Boix
SMSarah L. Morgan
Sarah L. Morgan
HMHansruedi Mathys
Hansruedi Mathys
WHWinston Hide
Winston Hide
Background: A significant proportion of individuals maintain cognition despite extensive Alzheimer’s disease (AD) pathology, known as cognitive resilience. Understanding the molecular mechanisms that protect these individuals could reveal therapeutic targets for AD. Methods: This study defines molecular and cellular signatures of cognitive resilience by integrating bulk RNA and single-cell transcriptomic data with genetics across multiple brain regions. We analyzed data from the Religious Order Study and the Rush Memory and Aging Project (ROSMAP), including bulk RNA sequencing ( n = 631 individuals) and multiregional single-nucleus RNA sequencing ( n = 48 individuals). Subjects were categorized into AD, resilient, and control based on β-amyloid and tau pathology, and cognitive status. We identified and prioritized protected cell populations using whole-genome sequencing-derived genetic variants, transcriptomic profiling, and cellular composition. Results: Transcriptomics and polygenic risk analysis position resilience as an intermediate AD state. Only GFAP and KLF4 expression distinguished resilience from controls at tissue level, whereas differential expression of genes involved in nucleic acid metabolism and signaling differentiated AD and resilient brains. At the cellular level, resilience was characterized by broad downregulation of LINGO1 expression and reorganization of chaperone pathways, specifically downregulation of Hsp90 and upregulation of Hsp40, Hsp70, and Hsp110 families in excitatory neurons. MEF2C, ATP8B1, and RELN emerged as key markers of resilient neurons. Excitatory neuronal subtypes in the entorhinal cortex (ATP8B+ and MEF2C high ) exhibited unique resilience signaling through activation of neurotrophin (BDNF-NTRK2, modulated by LINGO1) and angiopoietin (ANGPT2-TEK) pathways. MEF2C+ inhibitory neurons were over-represented in resilient brains, and the expression of genes associated with rare genetic variants revealed vulnerable somatostatin (SST) cortical interneurons that survive in AD resilience. The maintenance of excitatory-inhibitory balance emerges as a key characteristic of resilience. Conclusions: We have defined molecular and cellular hallmarks of cognitive resilience, an intermediate state in the AD continuum. Resilience mechanisms include preserved neuronal function, balanced network activity, and activation of neurotrophic survival signaling. Specific excitatory neuronal populations appear to play a central role in mediating cognitive resilience, while a subset of vulnerable interneurons likely provides compensation against AD-associated hyperexcitability. This study offers a framework to leverage natural protective mechanisms to mitigate neurodegeneration and preserve cognition in AD.

28 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
YPYered Pita-Juarez
Yered Pita-Juarez
DKDimitra Karagkouni
Dimitra Karagkouni
NKNikolaos Kalavros
Nikolaos Kalavros
JMJohannes C. Melms
Johannes C. Melms
SNSebastian Niezen
Sebastian Niezen
IVIoannis Vlachos
Ioannis Vlachos
The molecular underpinnings of organ dysfunction in acute COVID-19 and its potential long-term sequelae are under intense investigation. To shed light on these in the context of liver function, we performed single-nucleus RNA-seq and spatial transcriptomic profiling of livers from 17 COVID-19 decedents. We identified hepatocytes positive for SARS-CoV-2 RNA with an expression phenotype resembling infected lung epithelial cells. Integrated analysis and comparisons with healthy controls revealed extensive changes in the cellular composition and expression states in COVID-19 liver, reflecting hepatocellular injury, ductular reaction, pathologic vascular expansion, and fibrogenesis. We also observed Kupffer cell proliferation and erythrocyte progenitors for the first time in a human liver single-cell atlas, resembling similar responses in liver injury in mice and in sepsis, respectively. Despite the absence of a clinical acute liver injury phenotype, endothelial cell composition was dramatically impacted in COVID-19, concomitantly with extensive alterations and profibrogenic activation of reactive cholangiocytes and mesenchymal cells. Our atlas provides novel insights into liver physiology and pathology in COVID-19 and forms a foundational resource for its investigation and understanding.

25 March 2019 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
PYPourya Naderi Yeganeh
Pourya Naderi Yeganeh
MMM. Taghi Mostafavi
M. Taghi Mostafavi
Pathway enrichment analysis models (PEM) are the premier methods for interpreting genetic perturbations from high-throughput experiments. PEM often use a priori background knowledge to infer the underlying biological functions and mechanisms. A shortcoming of standard PEM is their disregarding of genetic interactions for mathematical simplicity, which potentially results in partial and inaccurate inference. In this study, we introduce a graph-based PEM, namely Causal Disturbance Analysis (CADIA), that leverages genetic interactions to quantify the topological importance of perturbations in pathway organizations. In particular, CADIA uses a novel graph centrality model, namely Source/Sink, to measure the topological importance. Source/Sink Centrality quantifies a gene's importance as a receiver and a sender of biological information, which allows for prioritizing the perturbations that are more likely to disturb a pathway's functionality. CADIA infers an enrichment score for a pathway by deriving statistical evidence from Source/Sink centrality of the perturbed genes and combines it with classical over-representation analysis. Through real-world experimental and synthetic data evaluations, we show that CADIA can uniquely infer critical pathway enrichments that are not observable through other PEM. Our results indicate that CADIA is sensitive towards topologically central perturbations and provides a robust framework for interpreting high-throughput data.

28 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
IAIrais Erendira Valenzuela Arzeta
Irais Erendira Valenzuela Arzeta
PYPourya Naderi Yeganeh
Pourya Naderi Yeganeh
ARAnupama Rai
Anupama Rai
JBJane Banahan
Jane Banahan
AIArtemis Iatrou
Artemis Iatrou
MMMaria Mavrikaki
Maria Mavrikaki
Aging of the human brain is characterized by widespread changes in gene expression regulated in part by microRNAs (miRNAs). We present a lifespan miRNA atlas of the human dorsolateral prefrontal cortex generated from small RNA sequencing of 113 postmortem samples spanning 18 to 100 years of age. Differential expression analysis revealed progressive age-associated remodeling of miRNA expression, with the strongest differences observed between old and young individuals. Among the significantly altered miRNAs, miR-34a-5p emerged as one of the most robustly upregulated miRNAs in the aged cortex, alongside additional aging-associated miRNAs including miR-155-5p, miR-132-3p, miR-212-3p, miR-449a, and members of the miR-302 family. This atlas provides a resource for investigating miRNA dysregulation and small RNA regulatory networks during human cortical aging.

27 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
GPGiulia Pegoraro
Giulia Pegoraro
MIMehmet Enis Isgoren
Mehmet Enis Isgoren
LRLivia C Rizzo
Livia C Rizzo
LMLarisa Soto Morales
Larisa Soto Morales
PYPourya Naderi Yeganeh
Pourya Naderi Yeganeh
WHWinston Hide
Winston Hide
Systematic prioritization of candidate Alzheimer’s disease (AD) genes and their target functions for therapeutic intervention requires a consistent understanding of their brain location, cell-type-specific expression, relationships with pathology, and direction of change. Defining the role of a gene in AD requires interrogation of multiple publications, each providing a different context. Often, it is also unclear whether a gene is up-or downregulated across these contexts. However, the narrow diversity of contexts in which they have been assayed and described limits interpretation. We integrated 1,562 gene signatures from 34 studies, annotated for pathological process, cell type, brain region, and direction of change, and showed that Genedex recovers established AD biology. Genedex addresses cellular and regional unexplained directional contradictions from 10,657 discordant genes in the published AD literature. We investigated the role of heat-shock chaperones and neurotrophic signaling in cognitive resilience using Genedex. Heat-shock chaperone genes are broadly upregulated with tau burden; but, in the presence of amyloid pathology, their expression diverges, showing upregulation in excitatory neurons and downregulation in glia and during Aβ clearance. LINGO1 , a regulator of BDNF, is upregulated with neuritic plaque load, tau burden, and selective vulnerability in cortical regions. Notably, in tau-affected RORB ⁺ excitatory neurons, LINGO1 expression is inversely correlated with neurotrophic genes BDNF and NTRK2. A prioritized interneuronal resilience signature shows correlated pathway co-expression with somatostatin and parvalbumin interneuronal signatures. Vulnerability-associated signatures separate by cellular context: neuronal programs are positively correlated with vulnerable interneurons, while glial and vascular cells are predominantly anti-correlated. By systematically mapping genes across functional, cellular, spatial, and directional axes, Genedex provides a platform for discovery of contextualized targets and mechanistic hypotheses. Genedex is freely available at hidelab.github.io/genedex-app.